Frontiers in Precision Medicine II: Cancer, Big Data and the Public

Authors

Emily Coonrod, University of Utah
Jorge L. Contreras, S.J. Quinney College of Law, University of UtahFollow
Willard Dere, University of Utah
Jeffrey Botkin, University of Utah
Leslie Francis, S.J. Quinney College of Law, University of UtahFollow
Jim Tabery, University of Utah

Document Type

Article

Publication Date

2017

Abstract

Precision medicine is being developed within a complex landscape of public policy, science, economics, law, and regulation. In these and other policy areas, the goal of developing individually-tailored therapies poses novel challenges for health care research, delivery and policy. In this symposium, a range of experts in genetics, medicine, bioinformatics, intellectual property, health economics and bioethics identified and discussed many of the pressing questions raised by the development and practice of precision medicine. These and other issues will need to be taken into account as precision medicine moves ahead and becomes the standard of medical practice and care in the United States and around the world.

Recommended Citation

Coonrod, Emily; Contreras, Jorge L.; Dere, Willard; Botkin, Jeffrey; Francis, Leslie; and Tabery, Jim, "Frontiers in Precision Medicine II: Cancer, Big Data and the Public" (2017). Utah Law Faculty Scholarship. 74.
https://dc.law.utah.edu/scholarship/74